Learn more about investing in Dalton Bioanalytics

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Dalton Bioanalytics
Digitizing blood for the future of human health
Founded
2019
Employees*
2-10
Funding to Date*
undisclosed
* Data source: Crunchbase
Austin Quach, PhD, CSO
"The only way to really automatically capture most of this information is to integrate multiple layers of bioinformation — a.k.a. multiomics. For example, genomics (DNA), transcriptomics (RNA), proteomics (proteins), microbiomics (microbes), metabolomics (metabolites), and exposomics (exposures), etc."
Instead of doing 30+ routine blood tests, you can just do all of them in a one-shot multi-omic assay

Dalton Bioanalytics has developed a new way of analyzing all of the different types of biochemicals in blood. Using tried-and-true liquid chromatography mass spectrometry, we measure proteins, lipids, electrolytes, metabolites, and other small molecules—providing a more complete analysis at a fraction of the cost. Using the data generated from our multiomic research platform, we will discover new algorithmic biomarkers and develop them into new and superior clinical tests for numerous unmet diagnostic needs.